Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Cat. No. : VAR-022
| Cat. No. | VAR-022 |
| Description | Monophosphoryl lipid A (MPL), is a chemically modified derivative of lipopolysaccharide that displays greatly reduced toxicity while maintaining most of the immunostimulatory activity of lipopolysaccharide. MPL has been shown to be capable of binding and activating Toll-like receptor 4 (TLR4), present on key antigen-presenting cells, which play an important role in the induction of the innate and subsequent adaptive immune responses. It has been used extensively in clinical trials as a component in prophylactic and therapeutic vaccines targeting infectious disease, cancer and allergies. |
| Product Type | Bacteria-derived Adjuvant |
| Stability | Stable for at least 2 years after receipt when stored at 4°C. |
| Purity | ≥99% |
| Storage | Store at 4°C; |
A: No, Monophosphoryl Lipid A from E. coli R515 is a chemically modified derivative of lipopolysaccharide, which shows greatly reduced toxicity while retaining most of the immune-stimulating activity of lipopolysaccharide.
A: MPL can bind to and activate Toll-like receptor 4 (TLR4), which plays an important role in inducing innate and subsequent adaptive immune responses.
A: No, this reagent is only for scientific research and cannot be used for relevant treatments.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
While ensuring immune stimulation activity, its toxicity to cells and organisms is low.
The delivery service is convenient, with home delivery available after purchase.
Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.